Freitag, 29.9.2023
9:45 – 10:15
Stand H.40
Apellis in Ophthalmology – Geographic Atrophy and beyond
Apellis Germany GmbH
Experte: Pascal Deschatelets
Meet the Apellis Co-Founder & Chief Scientific Officer Pascal Deschatelets to hear about the Apellis story, the science of C3 complement inhibition and Apellis’ ophthalmology pipeline.
9:45 – 10:15
Stand E.12
What the heLIOS – Ein sinnvoller Ansatz in der Glaukomtherapie
ELIOS Vidion GmbH
Experte: Herbert Reitsamer (Salzburg)
16:15 – 16:45
Stand H.40
Apellis in Ophthalmology – Geographic Atrophy and beyond
Apellis Germany GmbH
Experte: Pascal Deschatelets
Meet the Apellis Co-Founder & Chief Scientific Officer Pascal Deschatelets to hear about the Apellis story, the science of C3 complement inhibition and Apellis’ ophthalmology pipeline.
Samstag, 30.09.2023
9:45–10:15
Stand H.07
ROCK-Inhibitoren in der Anwendung Neue Wege in der Glaukom Therapie
Santen GmbH
Experte: Hagen Thieme (Magdeburg)
16:15 – 16:45
Stand E.12
What the heLIOS – Ein sinnvoller Ansatz in der Glaukomtherapie
ELIOS Vidion GmbH
Experte: Anselm Jünemann (Erlangen)